BIOMAT Database Logo BIOMAT Database Logo

Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy. 1981

Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr

The fertility in previously sterile women who conceived at least once following hMG/hCG-induced ovulation is investigated. The study comprises 141 women. The cumulative spontaneous pregnancy rate (CSPR) was calculated using life table analysis and was found to be 30.4% after 5 years. The CSPR for subsequent pregnancies reached 91.3% after 5 years. This figure is similar to that of normal parous women, although the study group (previously infertile women) requires a larger exposure period to attain the figure. The spontaneous abortion rate in the hMG/hCG-induced pregnancies was 29%; whereas in subsequent spontaneous pregnancies this rate was 8.8%. This difference in rate was found to be statistically significant, and the possible reasons are discussed.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D008596 Menotropins Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations. Gonadotropins, Human Menopausal,Human Menopausal Gonadotropin,CP-89044,CP-90033,HMG Ferring,HMG Lepori,HMG Massone,Humegon,Menogon,Menopur,Menotrophin,Normegon,ORG-31338,Pergonal,Pergonal-500,CP 89044,CP 90033,CP89044,CP90033,Gonadotropin, Human Menopausal,Human Menopausal Gonadotropins,Lepori, HMG,Menopausal Gonadotropin, Human,ORG 31338,ORG31338,Pergonal 500,Pergonal500
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D009839 Oligomenorrhea Abnormally infrequent menstruation. Oligomenorrheas
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005687 Galactorrhea Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA. Galactorrheas
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Successful quadruplet pregnancy following ovulation induced with human menopausal gonadotropin and human chorionic gonadotropin.
January 1974, Acta obstetricia et gynecologica Scandinavica,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin.
December 1990, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Detrimental effect of endometrial biopsies on pregnancy rate following human menopausal gonadotropin/human chorionic gonadotropin-induced ovulation.
June 1980, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.
September 1984, Obstetrics and gynecology,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
February 1987, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations.
July 1993, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
March 1983, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin.
June 2003, Fertility and sterility,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
[Anovulatory sterility. Treatment with human menopausal gonadotropin and human chorionic gonadotropin].
February 1984, Ugeskrift for laeger,
Z Ben-Rafael, and S Mashiach, and G Oelsner, and D Farine, and B Lunenfeld, and D M Serr
Management of multiple conceptions after gonadotropin-releasing hormone analog/human menopausal gonadotropin/human chorionic gonadotropin therapy.
April 1988, Fertility and sterility,
Copied contents to your clipboard!